Roy Sudipta, Meena Tanushree, Lim Se-Jung
Artificial Intelligence & Data Science, Jio Institute, Navi Mumbai 410206, India.
Division of Convergence, Honam University, 120, Honamdae-gil, Gwangsan-gu, Gwangju 62399, Korea.
Diagnostics (Basel). 2022 Oct 20;12(10):2549. doi: 10.3390/diagnostics12102549.
The global healthcare sector continues to grow rapidly and is reflected as one of the fastest-growing sectors in the fourth industrial revolution (4.0). The majority of the healthcare industry still uses labor-intensive, time-consuming, and error-prone traditional, manual, and manpower-based methods. This review addresses the current paradigm, the potential for new scientific discoveries, the technological state of preparation, the potential for supervised machine learning (SML) prospects in various healthcare sectors, and ethical issues. The effectiveness and potential for innovation of disease diagnosis, personalized medicine, clinical trials, non-invasive image analysis, drug discovery, patient care services, remote patient monitoring, hospital data, and nanotechnology in various learning-based automation in healthcare along with the requirement for explainable artificial intelligence (AI) in healthcare are evaluated. In order to understand the potential architecture of non-invasive treatment, a thorough study of medical imaging analysis from a technical point of view is presented. This study also represents new thinking and developments that will push the boundaries and increase the opportunity for healthcare through AI and SML in the near future. Nowadays, SML-based applications require a lot of data quality awareness as healthcare is data-heavy, and knowledge management is paramount. Nowadays, SML in biomedical and healthcare developments needs skills, quality data consciousness for data-intensive study, and a knowledge-centric health management system. As a result, the merits, demerits, and precautions need to take ethics and the other effects of AI and SML into consideration. The overall insight in this paper will help researchers in academia and industry to understand and address the future research that needs to be discussed on SML in the healthcare and biomedical sectors.
全球医疗保健行业持续快速增长,是第四次工业革命(4.0)中发展最快的行业之一。大多数医疗保健行业仍采用劳动密集型、耗时且容易出错的传统、手工和基于人力的方法。本综述探讨了当前的范式、新科学发现的潜力、技术准备状态、各种医疗保健领域中监督机器学习(SML)的前景以及伦理问题。评估了疾病诊断、个性化医疗、临床试验、非侵入性图像分析、药物发现、患者护理服务、远程患者监测、医院数据和纳米技术在医疗保健领域各种基于学习的自动化中的有效性和创新潜力,以及医疗保健中对可解释人工智能(AI)的要求。为了理解非侵入性治疗的潜在架构,从技术角度对医学影像分析进行了深入研究。本研究还代表了新的思维和发展趋势,这些将在不久的将来通过人工智能和监督机器学习拓展医疗保健的边界并增加机会。如今,基于监督机器学习的应用需要高度的数据质量意识,因为医疗保健领域数据量大,知识管理至关重要。如今,生物医学和医疗保健发展中的监督机器学习需要技能、对数据密集型研究的数据质量意识以及以知识为中心的健康管理系统。因此,需要考虑人工智能和监督机器学习的伦理及其他影响的优缺点和注意事项。本文的整体见解将帮助学术界和工业界的研究人员理解和应对医疗保健和生物医学领域中关于监督机器学习需要讨论的未来研究。